News & Announcements

Agena Bioscience Granted EUA for High-Throughput, Low-Cost SARS-CoV-2 Panel

October 28th, 2020|

Agena Bioscience®, a global provider of low-cost and high-throughput molecular testing solutions, today announced that its MassARRAY® SARS-CoV-2 Panel for qualitative detection of the SARS-CoV-2 coronavirus has been granted Emergency Use Authorization from the U.S. Food and Drug Administration (FDA) [...]